Fisetin vs Quercetin: What the Evidence Actually Shows About These Two Flavonoids
Fisetin and quercetin are both flavonoids studied as senolytics, but their evidence profiles differ significantly. Here is an honest comparison.
Fisetin and Skin Aging: What the Research Says About Senescent Cell Clearance in Dermal Tissue
Fisetin is under study as a senolytic compound that may clear senescent cells in the dermis. Here is what the current evidence actually shows.
Is Fisetin Safe for Older Adults? A Review of the Current Evidence
An honest, evidence-based review of fisetin safety for older adults: the senolytic hypothesis, preclinical findings, drug interactions, and real evidence limits
AFFIRM-LITE: What Mayo Clinic’s First Human Fisetin Frailty Trial Actually Found
A plain-language look at AFFIRM-LITE, Mayo Clinic’s pilot trial testing fisetin as a senolytic in older adults with physical dysfunction and frailty.
Fisetin Dosage: How Much to Take, When, and Safety Notes (2026)
As we navigate the complexities of aging, the quest for interventions that genuinely promote healthspan continues to intensify. Fisetin, a
Fisetin Cost Per Dose: A Practical Value Analysis for Supplement Buyers
Break down fisetin cost per dose, learn what drives pricing, and find out how to evaluate quality without overpaying. Informational only, not medical advice.
Fisetin and Bone Health: What Preclinical Research on Osteoclast Inhibition Actually Shows
Fisetin, a plant flavonoid, has shown osteoclast-inhibiting effects in preclinical models via NF-κB and MKP-1 pathways. Here is what the evidence says.
Fisetin Dosage: What Research Protocols Use vs. What Supplements Contain
A clear breakdown of fisetin dosage — from preclinical and early human senolytic research to commercial supplement amounts — and why the gap matters.
Fisetin’s Anti-Inflammatory Mechanisms: What the Research Actually Shows
Fisetin targets NF-κB, MAPK, JAK/STAT, and other inflammatory pathways. Here is what preclinical evidence reveals—and where the human data stands.